TipRanks
Cimpress NV (CMPR)
NASDAQ:CMPR
Want to see CMPR full AI Analyst Report?

Cimpress (CMPR) AI Stock Analysis

229 Followers

Top Page

CMPR

Cimpress

(NASDAQ:CMPR)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - Gpt-5.6Sol)
Rating:58Neutral
Price Target:
$81.00
▼(-7.83% Downside)
Action:Reiterated
Date:08/08/26
CMPR scores 58 primarily due to mixed financial performance: reliable cash generation and growth are offset by a stressed capital structure (high debt and negative equity) and thin/volatile profitability. The earnings call provides meaningful support with raised medium-term targets and a clearer deleveraging path, while technicals are near-neutral and valuation remains a key headwind given the high P/E.
Positive Factors
Revenue and EBITDA growth
Cimpress is expanding revenue while converting that growth into higher adjusted EBITDA, indicating improving operating scale. Management’s FY2027 and FY2028 targets imply continued earnings progression, which can strengthen reinvestment capacity and competitive positioning over the next several quarters.
Negative Factors
High leverage and negative equity
Cimpress’s high debt and persistent negative equity leave less balance-sheet capacity to absorb weaker earnings or unexpected costs. Although leverage has recently improved, the stressed capital structure can keep debt service significant and constrain investments or other capital allocation decisions.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue and EBITDA growth
Cimpress is expanding revenue while converting that growth into higher adjusted EBITDA, indicating improving operating scale. Management’s FY2027 and FY2028 targets imply continued earnings progression, which can strengthen reinvestment capacity and competitive positioning over the next several quarters.
Read all positive factors

Cimpress Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Shows where revenue comes from across regions such as North America, Europe and other markets, revealing geographic concentration, exposure to currency swings, and where the biggest growth opportunities or risks lie for scaling the mass-customization model.
Chart InsightsEurope has transitioned from a secondary to the largest revenue market, with stronger year‑over‑year Q4 ramps through 2024–25 that suggest improving European demand/pricing or successful local execution; North America still grows but with more muted acceleration. The Other bucket is noisy — a mid‑2023 plunge looks like a one‑off (restructuring/divestiture or reporting change) and has since partially recovered. Seasonality (big Q4 spikes) and regional FX/execution risks mean headline growth could be lumpy; focus on sustaining Europe momentum and margin mix next quarters.
Data provided by:The Fly

Cimpress (CMPR) vs. SPDR S&P 500 ETF (SPY)

Cimpress Business Overview & Revenue Model

Company Description
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. It operates through five segments: Vista, PrintBrothers, The Print Group, National Pen, and All Other Businesses. The ...
How the Company Makes Money
Cimpress makes money primarily by selling customized print and promotional products through its e-commerce and digitally enabled order channels. Customers design or configure items (often via online design tools and templates), place orders, and p...

Cimpress Earnings Call Summary

Earnings Call Date:Jul 29, 2026
(Q4-2026)
|
% Change Since: |
Next Earnings Date:Oct 28, 2026
Earnings Call Sentiment Positive
The call communicated clear operational progress and a confident multi-year financial plan: revenue and adjusted EBITDA grew in fiscal 2026, Vistaprint customer profitability improved, strategic moves (Canva partnership and Saxoprint acquisition) were highlighted, and management raised FY2028 EBITDA and cash-flow targets while guiding to lower leverage. The main negatives were a set of end-of-quarter, largely one-time or timing-driven items (duty drawback write-off, higher start-up costs, inventory write-downs), tariff uncertainty related to a potential 50% Canada duty, and elevated near-term CapEx that compressed FY2026 free cash flow. Overall, positives (growth, margin target raises, balance-sheet improvements, and strategic partnerships) materially outweigh the identifiable, mostly transitory lowlights.
Positive Updates
Revenue Growth (FY2026 and Q4)
Full-year revenue for fiscal 2026 was $3.74 billion, up 10% on a reported basis and up 4% on an organic constant-currency basis. Q4 consolidated revenue grew 9% reported and 3% organic constant-currency.
Negative Updates
Q4 Profitability Headwinds and Miss vs Guidance
Q4 adjusted EBITDA was below updated guidance mainly due to several end-of-quarter items: $7.1 million higher start-up costs for North American manufacturing build-out, a $4.7 million write-off of Canadian duty drawback receivables, $1.8 million inventory write-downs, and an adjustment for variable long-term incentives. Management noted roughly $10 million of negative impact on adjusted EBITDA from the duty drawback/inventory/compensation adjustment and about $2 million from unfavorable currency movement and Saxoprint transaction costs.
Read all updates
Q4-2026 Updates
Negative
Revenue Growth (FY2026 and Q4)
Full-year revenue for fiscal 2026 was $3.74 billion, up 10% on a reported basis and up 4% on an organic constant-currency basis. Q4 consolidated revenue grew 9% reported and 3% organic constant-currency.
Read all positive updates
Company Guidance
Cimpress guided to continued profitable growth: after FY26 results of $3.74B revenue (+10% reported, +4% organic), $458.5M adjusted EBITDA, $122.4M adjusted free cash flow and 2.9x net leverage, management expects for FY27 at least 7% reported revenue growth (≈3% organic constant-currency), net income of at least $125M, adjusted EBITDA of at least $520M (>13% YoY), operating cash flow ≈ $370M and adjusted free cash flow ≈ $200M; they expect M&A to add $18–21M of EBITDA on $165–175M of revenue, currency to help by $5–10M, and the balance ($31–39M) from organic growth and cost efficiencies, with CapEx and capitalized software roughly flat to FY26 and tariffs (Section 301) largely baked in (Section 338 excluded). For FY28 management raised targets to organic revenue growth of 4–6%, net income of at least $192M, adjusted EBITDA of at least $615M (up from $600M) and ~45% adjusted free cash flow conversion (implying ~ $275M adj. FCF), with net leverage expected to fall to ~2.5x exiting FY27 and meaningfully below 2.0x by end of FY28 (subject to capital allocation).

Cimpress Financial Statement Overview

Summary
Mixed fundamentals: steady revenue growth and consistently positive free cash flow support the business, but profitability has been volatile with thin recent net margins. The balance sheet is a major constraint, with high debt and persistent negative equity reducing financial flexibility despite improved leverage.
Income Statement
58
Neutral
Balance Sheet
28
Negative
Cash Flow
64
Positive
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue3.74B3.40B3.29B3.08B2.89B
Gross Profit1.73B1.62B1.60B1.44B1.39B
EBITDA410.48M353.32M400.03M245.00M284.44M
Net Income95.87M14.95M173.68M-185.98M-54.33M
Balance Sheet
Total Assets2.20B1.97B1.89B1.85B2.17B
Cash, Cash Equivalents and Short-Term Investments248.85M233.98M208.28M168.85M327.00M
Total Debt1.75B1.71B1.72B1.76B1.79B
Total Liabilities2.68B2.53B2.41B2.47B2.53B
Stockholders Equity-493.99M-583.49M-550.15M-623.14M-494.92M
Cash Flow
Free Cash Flow183.46M144.95M295.79M18.73M100.20M
Operating Cash Flow283.71M298.07M350.72M130.29M219.54M
Investing Cash Flow-195.56M-140.76M-54.61M-103.72M-4.00M
Financing Cash Flow-68.02M-135.92M-222.55M-177.11M-106.57M

Cimpress Technical Analysis

Technical Analysis Sentiment
Negative
Last Price87.88
Price Trends
50DMA
89.91
Negative
100DMA
92.64
Negative
200DMA
84.10
Negative
Market Momentum
MACD
-3.21
Positive
RSI
30.00
Positive
STOCH
39.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CMPR, the sentiment is Negative. The current price of 87.88 is above the 20-day moving average (MA) of 82.91, below the 50-day MA of 89.91, and above the 200-day MA of 84.10, indicating a bearish trend. The MACD of -3.21 indicates Positive momentum. The RSI at 30.00 is Positive, neither overbought nor oversold. The STOCH value of 39.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CMPR.

Cimpress Risk Analysis

Cimpress disclosed 35 risk factors in its most recent earnings report. Cimpress reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Cimpress Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
$568.20M14.5712.58%4.45%2.27%-5.62%
74
Outperform
$79.23B38.5442.08%0.95%9.51%12.27%
66
Neutral
$1.08B10.7114.63%5.11%0.30%71.14%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
$478.94M14.4626.19%4.03%-8.02%―
58
Neutral
$1.90B20.05-18.09%―9.80%563.10%
51
Neutral
$34.51M-6.02-30.13%10.90%-11.62%-87.59%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CMPR
Cimpress
78.17
15.37
24.47%
CTAS
Cintas
197.74
-3.87
-1.92%
DLX
Deluxe
23.50
4.98
26.88%
EBF
Ennis
22.46
5.10
29.36%
HHS
Harte-Hanks
4.63
0.95
25.71%
QUAD
Quad/Graphics
9.30
3.50
60.40%

Cimpress Corporate Events

Business Operations and StrategyM&A Transactions
Cimpress Completes Acquisition of SAXOPRINT and Viaprinto
Positive
Jul 2, 2026
On July 2, 2026, Cimpress plc completed its acquisition of the SAXOPRINT and viaprinto businesses from CEWE Stiftung Co. KGaA, following an earlier announcement on May 11, 2026. The acquired operations will be integrated into Cimpress’s Pri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 08, 2026